{"id":"letermovir-intravenous","safety":{"commonSideEffects":[{"rate":"34%","effect":"Nausea"},{"rate":"24%","effect":"Diarrhea"},{"rate":"21%","effect":"Fatigue"},{"rate":"17%","effect":"Headache"},{"rate":"14%","effect":"Vomiting"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Letermovir is a viral replication inhibitor that specifically targets the HCMV terminase complex, preventing viral DNA maturation and replication.","oneSentence":"Inhibits human cytomegalovirus (HCMV) replication by targeting the viral terminase complex","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:03:23.739Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of cytomegalovirus (CMV) infection in adult recipients of an allogeneic hematopoietic stem cell transplant"}]},"trialDetails":[{"nctId":"NCT03930615","phase":"PHASE3","title":"Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-06-21","conditions":"Cytomegalovirus Infection","enrollment":220},{"nctId":"NCT03940586","phase":"PHASE2","title":"Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-08-08","conditions":"Cytomegalovirus (CMV) Infection","enrollment":65},{"nctId":"NCT04129398","phase":"PHASE3","title":"MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-12-27","conditions":"Cytomegalovirus Infection, Cytomegalovirus Disease","enrollment":22},{"nctId":"NCT06211543","phase":"","title":"Letermovir (LMV) Prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients With CMV Seropositive Donors: an Exploratory Study From Spanish GETH/TC Centers","status":"NOT_YET_RECRUITING","sponsor":"Grupo Espanol de trasplantes hematopoyeticos y terapia celular","startDate":"2024-03-30","conditions":"CMV","enrollment":80},{"nctId":"NCT03728426","phase":"PHASE2","title":"Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection","status":"COMPLETED","sponsor":"Amy C. Sherman, MD","startDate":"2019-01-11","conditions":"Cytomegalovirus Infections","enrollment":10},{"nctId":"NCT02137772","phase":"PHASE3","title":"Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2014-06-06","conditions":"Prevention of CMV Infection or Disease","enrollment":570}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":23,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["MK-8228","AIC246","AIC001"],"phase":"phase_2","status":"active","brandName":"Letermovir intravenous","genericName":"Letermovir intravenous","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Inhibits human cytomegalovirus (HCMV) replication by targeting the viral terminase complex Used for Prevention of cytomegalovirus (CMV) infection in adult recipients of an allogeneic hematopoietic stem cell transplant.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}